Modularisation of published and novel models toward a complex KIR2DL4 pathway in pbNK cell.
Intracellular signalling pathway
Mathematical model
Modularisation
Journal
MethodsX
ISSN: 2215-0161
Titre abrégé: MethodsX
Pays: Netherlands
ID NLM: 101639829
Informations de publication
Date de publication:
2022
2022
Historique:
received:
21
02
2022
accepted:
10
06
2022
entrez:
1
7
2022
pubmed:
2
7
2022
medline:
2
7
2022
Statut:
epublish
Résumé
KIR2DL4 is an interesting receptor expressed on the peripheral blood natural killer (pbNK) cell as it can be either activating or inhibitory depending on the amino acid residues in the domain. This model uses mathematical modelling to investigate the downstream effects of natural killer cells' activation (KIR2DL4) receptor after stimulation by key ligand (HLA-G) on pbNK cells. Development of this large pathway is based on a comprehensive qualitative description of pbNKs' intracellular signalling pathways leading to chemokine and cytotoxin secretion, obtained from the KEGG database (https://www.genome.jp/pathway/hsa04650). From this qualitative description we built a quantitative model for the pathway, reusing existing curated models where possible and implementing new models as needed. This model employs a composite approach for generating modular models. The approach allows for the construction of large-scale complex model by combining component of sub-models that can be modified individually. This large pathway consists of two published sub-models; the Ca
Identifiants
pubmed: 35774414
doi: 10.1016/j.mex.2022.101760
pii: S2215-0161(22)00140-6
pmc: PMC9237949
doi:
Types de publication
Journal Article
Langues
eng
Pagination
101760Informations de copyright
© 2022 The Author(s). Published by Elsevier B.V.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Cold Spring Harb Perspect Biol. 2011 Mar 01;3(3):
pubmed: 21421924
Nature. 1998 Apr 30;392(6679):933-6
pubmed: 9582075
J Immunol. 1994 Jan 1;152(1):270-9
pubmed: 7504712
J Biol Chem. 2008 Nov 21;283(47):32650-9
pubmed: 18818202
J Biol Chem. 1997 Nov 28;272(48):30412-20
pubmed: 9374532
Mol Biol Cell. 1995 Sep;6(9):1145-58
pubmed: 8534912
J Immunol. 2003 Apr 1;170(7):3769-81
pubmed: 12646643
Biochem J. 2003 Jul 15;373(Pt 2):451-63
pubmed: 12691603
PLoS Biol. 2006 Jan;4(1):e9
pubmed: 16366734
J Exp Med. 1995 Sep 1;182(3):801-10
pubmed: 7650486
Cell Calcium. 1997 Nov;22(5):321-31
pubmed: 9448939
J Biol Chem. 1995 Sep 1;270(35):20264-72
pubmed: 7544786
J Exp Med. 1992 Dec 1;176(6):1751-5
pubmed: 1281218
Science. 2004 Nov 19;306(5700):1374-7
pubmed: 15550671
J Exp Med. 1992 Dec 1;176(6):1745-50
pubmed: 1281217
Biophys J. 2009 Mar 18;96(6):2095-104
pubmed: 19289036
EMBO J. 2003 Aug 1;22(15):3825-32
pubmed: 12881417